Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

13 Aug 2019 15:19

RNS Number : 9065I
Income & Growth VCT (The) PLC
13 August 2019
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2019

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2019. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2019

At 31 March 2019

 

Net assets attributable to shareholders

£84,211,371

£81,438,038

Shares in issue

103,827,380

104,363,865

Net asset value (NAV) per share

81.11p*

78.03p

Cumulative dividends paid to date per share

111.50p*

111.50p

Total return per share since inception (NAV basis)

192.61p

189.53p

*Figures are quoted prior to the 1.50 pence dividend referred to below.

 

INTERIM DIVIDEND

 

The Board declared an interim dividend of 1.50 pence per share for the year ending 30 September 2019, comprising 1.00 penny and 0.50 pence from capital. This dividend was paid to shareholders on 12 July 2019 to shareholders on the Register on 14 June 2019 and brings cumulative dividends paid per share to 113.00 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

SHARE BUYBACKS

 

On 5 June 2019, the Company purchased 300,000 of the Company's own ordinary shares at a price of 67.50 pence per share for cancellation.

 

On 7 June 2019, the Company purchased 236,485 of the Company's own ordinary shares at a price of 70.25 pence for cancellation.

 

After the period end, with effect from 1 August 2019, the Board changed its share buyback policy objective of maintaining the discount to Net Asset Value at which the Company's shares may trade in the market from approximately 10% or less, to approximately 5% or less. In pursuing this policy, the Board's priority will remain to ensure that it is acting prudently and in the interests of the remaining shareholders of the Company. Share buybacks will continue to be entirely at the Board's discretion and will be subject to the Company having sufficient funds available for such a purpose. They will also continue to be subject to prevailing market conditions, the Listing Rules and any applicable law and regulatory restrictions at the relevant time. Shares bought back in the market will ordinarily be cancelled.

 

INVESTMENT ACTIVITY

 

Investments during the period

On 13 May 2019, the Company invested £1.53 million into a new investee company, Arkk Consulting, which provides services and software to enable organisations to remain compliant with regulatory reporting requirements.

 

On 22 May 2019, the Company invested £0.93 million into a new investee company, Parsley Box, which is a UK direct to consumer supplier of home delivered ambient ready meals for the elderly.

 

Realisations during the period

On 10 May 2019, the Company sold its remaining investment in Plastic Surgeon to Polygon Group for £1.22 million. Over the eleven years this investment was held, it generated proceeds of £2.27 million compared to an original investment cost £0.41 million, which is a multiple on cost of 5.6 x and an IRR of 20.5%.

 

On 28 June 2019, the Company sold its investment in ASL Technology for £4.79 million. Over the eight and a half years this investment was held, it generated proceeds of £5.94 million compared to an original investment cost of £2.72 million, which is a multiple on cost of 2.2x and an IRR of 12.6%.

 

Transactions after the period end

After the period end, the Company made a follow-on investment of £0.62 million into MPB Group, a leading online marketplace for camera and video equipment.

 

On 2 August 2019, £0.17 million of contingent consideration was received as part of the sale of Entanet Holdings in August 2017.

On 6 June 2019, the Company realised part of its investment in Master Removers Group generating proceeds receivable of £0.51 million, as part of a transaction which also increased the Company's equity interest from 6.3% to 9.6%.

 

PLANNED FUNDRAISING

As announced recently, the Board intends to launch offers for subscription for new ordinary shares in the autumn, full details of which will be contained in the prospectus that will be sent to all registered shareholders.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Rob Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORSRKKAWAAR
Date   Source Headline
15th Jan 201512:35 pmRNSDirector/PDMR Shareholding
15th Jan 201512:25 pmRNSIssue of Equity
23rd Dec 20143:18 pmRNSAnnual Financial Report
23rd Dec 201412:39 pmRNSOffer Update
19th Dec 20144:51 pmRNSIssue of Supplementary Prospectus
19th Dec 20142:24 pmRNSTransaction in Own Shares
17th Dec 20143:09 pmRNSReplacement Annual Financial Report
17th Dec 20142:33 pmRNSAnnual Financial Report
10th Dec 20145:41 pmRNSOffer for Subscription - Launch
11th Nov 20149:11 amRNSTotal Voting Rights
30th Oct 20143:11 pmRNSDirector/PDMR Shareholding
30th Oct 20143:00 pmRNSIssue of Equity
22nd Oct 20143:13 pmRNSIntention to launch offeres for subscription
1st Oct 201412:40 pmRNSTotal Voting Rights
30th Sep 20149:25 amRNSTransaction in Own Shares
18th Sep 201411:51 amRNSInterim Dividend
1st Sep 20144:25 pmRNSTotal Voting Rights
8th Aug 20148:58 amRNSInterim Management Statement
3rd Jul 20145:21 pmRNSDirector/PDMR Shareholding
3rd Jul 20145:17 pmRNSIssue of Equity
25th Jun 201411:13 amRNSTransaction in Own Shares
18th Jun 201411:23 amRNSDoc re. Half-Year Report 31 March 2014
6th Jun 201411:55 amRNSIssue of Equity
2nd Jun 20149:39 amRNSOffer Update
2nd Jun 20149:37 amRNSOffer Update
2nd Jun 20149:33 amRNSOffer Update
28th May 20143:00 pmRNSTransaction in Own Shares
23rd May 20147:00 amRNSHalf Yearly Report
29th Apr 20143:42 pmRNSOffer Update
16th Apr 20145:55 pmRNSOffer Update
16th Apr 20145:21 pmRNSOffer Update
7th Apr 201410:36 amRNSIssue of Equity
4th Apr 20149:10 amRNSIssue of Equity
3rd Apr 20146:29 pmRNSIssue of Equity
1st Apr 20149:05 amPRNIssue of Equity
26th Mar 201410:45 amPRNSupplementary Prospectus
24th Mar 20147:00 amPRNOffer Update
12th Feb 20143:51 pmPRNResult of AGM
12th Feb 20143:47 pmPRNDirector/PDMR Shareholding
12th Feb 20143:36 pmPRNIssue of Equity
6th Feb 20144:42 pmPRNTransaction in Own Shares
6th Feb 20149:23 amPRNTransaction in Own Shares
5th Feb 201410:25 amPRNInterim Management Statement
9th Jan 20145:41 pmPRNIssue of Equity
2nd Jan 201410:21 amPRNCorrection : Total Voting Rights
2nd Jan 20147:00 amPRNTotal Voting Rights
24th Dec 201312:17 pmPRNCorrection : Transaction in Own Shares
24th Dec 20139:35 amPRNTransaction in Own Shares
19th Dec 20132:15 pmPRNIssue of Supplementary Prospectus
19th Dec 20132:14 pmPRNIssue of Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.